Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Phase III study evaluates Axid OS for use in infants with GERD

Jan. 12, 2007

Prochymal receives fast track designation, set to begin phase III for Crohn's disease

Jan. 11, 2007

Novel therapeutic agents for gastrointestinal disorders claimed in recent patents

Jan. 9, 2007

Phase III Zadaxin triple therapy study in HCV completes enrollment

Jan. 2, 2007

Tibotec files to begin phase I testing of HCV NS3/4A protease inhibitor

Dec. 28, 2006

Kosan and Pfizer sign worldwide license agreement for motilin agonist program

Dec. 28, 2006

Heplisav begins pivotal phase III study for hepatitis B

Dec. 28, 2006

Second phase III study for intravenous methylnaltrexone in POI

Dec. 27, 2006

Pediatric indication approved for Colazal

Dec. 22, 2006

Hepatitis C protease inhibitor ITMN-191 studied in phase Ia European trial

Dec. 22, 2006